The global Peptide Library Screening Services market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Peptide library screening services involve the synthesis and screening of diverse peptide libraries to identify specific peptides that exhibit desired properties or activities. These services are typically utilized in drug discovery, biomarker identification, and protein-protein interaction studies. Peptide libraries consist of a large collection of peptides, each with a unique sequence, which are screened against target molecules to identify candidates with desired biological activities. Screening techniques can include high-throughput screening, affinity-based selection, or functional assays. These services provide researchers with access to a wide range of peptide sequences, accelerating the discovery and development of novel therapeutics, diagnostic tools, and molecular probes.
The market prospects for peptide library screening services are quite promising. The increasing demand for peptide-based therapeutics and diagnostics is driving the need for efficient and comprehensive screening methods. Peptide libraries offer a diverse range of sequences that can be screened against specific targets, enabling the discovery of novel peptides with desired properties. Pharmaceutical companies, academic institutions, and research organizations are actively utilizing these services for drug discovery, protein-protein interaction studies, and biomarker identification. Additionally, advancements in high-throughput screening technologies and the growing focus on personalized medicine further contribute to the market growth. The market for peptide library screening services is expected to witness steady expansion in the coming years.
The 鈥淧eptide Library Screening Services Industry Forecast鈥� looks at past sales and reviews total world Peptide Library Screening Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Peptide Library Screening Services sales for 2025 through 2031. With Peptide Library Screening Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide Library Screening Services industry.
This Insight Report provides a comprehensive analysis of the global Peptide Library Screening Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide Library Screening Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Peptide Library Screening Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide Library Screening Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide Library Screening Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Library Screening Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
Solid Phase Screening
Liquid Phase Screening
In Vivo Screening
Whole Cell Screening
Others
Segmentation by Application:
Pharmacy
Biotechnology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Biosynth
Synpeptide
NovoPro
Kaneka Eurogentec
Creative Peptides
KMD Bioscience
Nanjing Zoonbio Biotechnology
Nanjing GenScript Biotechnology
SBS Genetech
Zhongtai Biochemical
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Peptide Library Screening Services 麻豆原创 Size (2020-2031)
2.1.2 Peptide Library Screening Services 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Peptide Library Screening Services by Country/Region (2020, 2024 & 2031)
2.2 Peptide Library Screening Services Segment by Type
2.2.1 Solid Phase Screening
2.2.2 Liquid Phase Screening
2.2.3 In Vivo Screening
2.2.4 Whole Cell Screening
2.2.5 Others
2.3 Peptide Library Screening Services 麻豆原创 Size by Type
2.3.1 Peptide Library Screening Services 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Peptide Library Screening Services 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Peptide Library Screening Services Segment by Application
2.4.1 Pharmacy
2.4.2 Biotechnology
2.4.3 Others
2.5 Peptide Library Screening Services 麻豆原创 Size by Application
2.5.1 Peptide Library Screening Services 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Peptide Library Screening Services 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Peptide Library Screening Services 麻豆原创 Size by Player
3.1 Peptide Library Screening Services 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Peptide Library Screening Services Revenue by Player (2020-2025)
3.1.2 Global Peptide Library Screening Services Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Peptide Library Screening Services Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Peptide Library Screening Services by Region
4.1 Peptide Library Screening Services 麻豆原创 Size by Region (2020-2025)
4.2 Global Peptide Library Screening Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Peptide Library Screening Services 麻豆原创 Size Growth (2020-2025)
4.4 APAC Peptide Library Screening Services 麻豆原创 Size Growth (2020-2025)
4.5 Europe Peptide Library Screening Services 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Peptide Library Screening Services 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Peptide Library Screening Services 麻豆原创 Size by Country (2020-2025)
5.2 Americas Peptide Library Screening Services 麻豆原创 Size by Type (2020-2025)
5.3 Americas Peptide Library Screening Services 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Peptide Library Screening Services 麻豆原创 Size by Region (2020-2025)
6.2 APAC Peptide Library Screening Services 麻豆原创 Size by Type (2020-2025)
6.3 APAC Peptide Library Screening Services 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Peptide Library Screening Services 麻豆原创 Size by Country (2020-2025)
7.2 Europe Peptide Library Screening Services 麻豆原创 Size by Type (2020-2025)
7.3 Europe Peptide Library Screening Services 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Peptide Library Screening Services by Region (2020-2025)
8.2 Middle East & Africa Peptide Library Screening Services 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Peptide Library Screening Services 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Peptide Library Screening Services 麻豆原创 Forecast
10.1 Global Peptide Library Screening Services Forecast by Region (2026-2031)
10.1.1 Global Peptide Library Screening Services Forecast by Region (2026-2031)
10.1.2 Americas Peptide Library Screening Services Forecast
10.1.3 APAC Peptide Library Screening Services Forecast
10.1.4 Europe Peptide Library Screening Services Forecast
10.1.5 Middle East & Africa Peptide Library Screening Services Forecast
10.2 Americas Peptide Library Screening Services Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Peptide Library Screening Services Forecast
10.2.2 Canada 麻豆原创 Peptide Library Screening Services Forecast
10.2.3 Mexico 麻豆原创 Peptide Library Screening Services Forecast
10.2.4 Brazil 麻豆原创 Peptide Library Screening Services Forecast
10.3 APAC Peptide Library Screening Services Forecast by Region (2026-2031)
10.3.1 China Peptide Library Screening Services 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Peptide Library Screening Services Forecast
10.3.3 Korea 麻豆原创 Peptide Library Screening Services Forecast
10.3.4 Southeast Asia 麻豆原创 Peptide Library Screening Services Forecast
10.3.5 India 麻豆原创 Peptide Library Screening Services Forecast
10.3.6 Australia 麻豆原创 Peptide Library Screening Services Forecast
10.4 Europe Peptide Library Screening Services Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Peptide Library Screening Services Forecast
10.4.2 France 麻豆原创 Peptide Library Screening Services Forecast
10.4.3 UK 麻豆原创 Peptide Library Screening Services Forecast
10.4.4 Italy 麻豆原创 Peptide Library Screening Services Forecast
10.4.5 Russia 麻豆原创 Peptide Library Screening Services Forecast
10.5 Middle East & Africa Peptide Library Screening Services Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Peptide Library Screening Services Forecast
10.5.2 South Africa 麻豆原创 Peptide Library Screening Services Forecast
10.5.3 Israel 麻豆原创 Peptide Library Screening Services Forecast
10.5.4 Turkey 麻豆原创 Peptide Library Screening Services Forecast
10.6 Global Peptide Library Screening Services Forecast by Type (2026-2031)
10.7 Global Peptide Library Screening Services Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Peptide Library Screening Services Forecast
11 Key Players Analysis
11.1 Biosynth
11.1.1 Biosynth Company Information
11.1.2 Biosynth Peptide Library Screening Services Product Offered
11.1.3 Biosynth Peptide Library Screening Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Biosynth Main Business Overview
11.1.5 Biosynth Latest Developments
11.2 Synpeptide
11.2.1 Synpeptide Company Information
11.2.2 Synpeptide Peptide Library Screening Services Product Offered
11.2.3 Synpeptide Peptide Library Screening Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Synpeptide Main Business Overview
11.2.5 Synpeptide Latest Developments
11.3 NovoPro
11.3.1 NovoPro Company Information
11.3.2 NovoPro Peptide Library Screening Services Product Offered
11.3.3 NovoPro Peptide Library Screening Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 NovoPro Main Business Overview
11.3.5 NovoPro Latest Developments
11.4 Kaneka Eurogentec
11.4.1 Kaneka Eurogentec Company Information
11.4.2 Kaneka Eurogentec Peptide Library Screening Services Product Offered
11.4.3 Kaneka Eurogentec Peptide Library Screening Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Kaneka Eurogentec Main Business Overview
11.4.5 Kaneka Eurogentec Latest Developments
11.5 Creative Peptides
11.5.1 Creative Peptides Company Information
11.5.2 Creative Peptides Peptide Library Screening Services Product Offered
11.5.3 Creative Peptides Peptide Library Screening Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 Creative Peptides Main Business Overview
11.5.5 Creative Peptides Latest Developments
11.6 KMD Bioscience
11.6.1 KMD Bioscience Company Information
11.6.2 KMD Bioscience Peptide Library Screening Services Product Offered
11.6.3 KMD Bioscience Peptide Library Screening Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 KMD Bioscience Main Business Overview
11.6.5 KMD Bioscience Latest Developments
11.7 Nanjing Zoonbio Biotechnology
11.7.1 Nanjing Zoonbio Biotechnology Company Information
11.7.2 Nanjing Zoonbio Biotechnology Peptide Library Screening Services Product Offered
11.7.3 Nanjing Zoonbio Biotechnology Peptide Library Screening Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Nanjing Zoonbio Biotechnology Main Business Overview
11.7.5 Nanjing Zoonbio Biotechnology Latest Developments
11.8 Nanjing GenScript Biotechnology
11.8.1 Nanjing GenScript Biotechnology Company Information
11.8.2 Nanjing GenScript Biotechnology Peptide Library Screening Services Product Offered
11.8.3 Nanjing GenScript Biotechnology Peptide Library Screening Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Nanjing GenScript Biotechnology Main Business Overview
11.8.5 Nanjing GenScript Biotechnology Latest Developments
11.9 SBS Genetech
11.9.1 SBS Genetech Company Information
11.9.2 SBS Genetech Peptide Library Screening Services Product Offered
11.9.3 SBS Genetech Peptide Library Screening Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 SBS Genetech Main Business Overview
11.9.5 SBS Genetech Latest Developments
11.10 Zhongtai Biochemical
11.10.1 Zhongtai Biochemical Company Information
11.10.2 Zhongtai Biochemical Peptide Library Screening Services Product Offered
11.10.3 Zhongtai Biochemical Peptide Library Screening Services Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 Zhongtai Biochemical Main Business Overview
11.10.5 Zhongtai Biochemical Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
